Observational studyCancer chemotherapy and pharmacology2021

Analysis of pharmacogenomic factors for chemotherapy-induced nausea and vomiting in patients with breast cancer receiving doxorubicin and cyclophosphamide chemotherapy.

Daiki Tsuji et al.PubMed ↗Publisher ↗

No numbers read from the abstract.